Federal agency to review FDA response to baby formula recall
reuters.com
news
2022-06-02 14:41:47

Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermidRegister now for FREE unlimited access to Reuters.comJune 2 (Reuters) - A federal agency will start a review if the U.S. Food and Drug Administration (FDA) properly conducted its inspection of Abbott Laboratories' (ABT.N) Michigan plant and oversaw baby formula recalls that led to severe shortages in the United States.The review, which is expected to be completed in 2023, will be conducted by the U.
